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A prominent area of neuroscience research over the past 20 years has been the acute mod-
ulation of neuronal synaptic activity by Ca2+-dependent release of the transmitters ATP,
D-serine, and glutamate (called gliotransmitters) by astrocytes. Although the physiological
relevance of this mechanism is under debate, emerging evidence suggests that there are
critical factors in addition to Ca2+ that are required for gliotransmitters to be released from
astrocytes. Interestingly, these factors include activated microglia and the proinflammatory
cytokineTumor Necrosis Factor α (TNFα), chemotactic cytokine Stromal cell-Derived Factor-
1α (SDF-1α), and inflammatory mediator prostaglandin E2 (PGE2). Of note, microglial activa-
tion and release of inflammatory molecules from activated microglia and reactive astrocytes
can occur within minutes of a triggering stimulus. Therefore, activation of astrocytes
by inflammatory molecules combined with Ca2+ elevations may lead to gliotransmitter
release, and be an important step in the early sequence of events contributing to hyperex-
citability, excitotoxicity, and neurodegeneration in the damaged or diseased brain. In this
review, we will first examine evidence questioning Ca2+-dependent gliotransmitter release
from astrocytes in healthy brain tissue, followed by a close examination of recent work sug-
gesting that Ca2+-dependent gliotransmitter release occurs as an early event in the devel-
opment of neurological disorders and neuroinflammatory and neurodegenerative diseases.
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INTRODUCTION
Gliotransmission – defined as the rapid and regulated exocytosis
of gliotransmitters by astrocytes in an activity and Gq G-protein-
coupled receptor (GPCR), Ca2+-dependent manner – has contin-
ued to be an exciting area of neuroscience research ever since its
initial discovery in 1994 (Parpura et al., 1994). Because the tight
regulation provided by Ca2+ elevations and release by quantal-
like vesicular exocytosis are typical properties of a physiological
process (Bezzi et al., 2001), astrocytes have been touted as active,
not only supportive, partners in the control of rapid synaptic
communication in the healthy brain (Haydon, 2001; Volterra and
Meldolesi, 2005; Perea et al., 2009; Santello and Volterra, 2009).
However, studies using novel techniques to selectively evoke
or block Gq GPCR-mediated Ca2+ elevations in astrocytes have
failed to observe changes in neuronal excitatory synaptic activ-
ity indicative of gliotransmission (Fiacco et al., 2007; Petravicz
et al., 2008; Agulhon et al., 2010). This has raised controversy
as to whether gliotransmission actually occurs in healthy brain
tissue. Emerging evidence is providing a possible explanation
for this discrepancy: Ca2+ elevations alone are not sufficient
for gliotransmitter release by astrocytes. Additional factors such
as inflammatory molecules appear to be required. These mol-
ecules may not be present in adequate quantities in healthy
brain tissue to elicit sufficient gliotransmitter release to affect
synaptic transmission. However, accumulating evidence suggests
that in the early steps of inflammatory processes and in the
diseased or damaged brain, activated microglia, and astrocytes
engage in a partnership that transforms astrocytes, within sec-
onds to minutes, into competent gliotransmitter releasing cells.
As astrocytic gliotransmitters include ATP, d-serine, and gluta-
mate, reactive astrocytes could increase neuronal excitability and
contribute to excitotoxicity, synaptic damage, and pathogenesis of
disease. Therefore, inflammatory transduction pathways that reg-
ulate Ca2+-dependent release of gliotransmitters from astrocytes
are potential targets for therapy of neurological disorders as well
as neuroinflammatory and neurodegenerative disease.
In this review, we will first examine evidence questioning Ca2+-
dependent gliotransmitter release by astrocytes in the healthy
brain, including the mechanisms driving astrocyte Ca2+ eleva-
tions, differences in basal (resting) Ca2+ vs. activity-induced Ca2+
elevations, and the temporal relationship between activation of
postsynaptic receptors and astrocyte Ca2+ elevations. We will then
review evidence suggesting that activated microglia and release of
inflammatory mediators transform astrocytes into cells capable
of releasing gliotransmitters in a Ca2+-dependent manner in the
damaged or diseased brain.
EVIDENCE QUESTIONING GLIOTRANSMISSION IN HEALTHY
BRAIN TISSUE
WHAT IS GLIOTRANSMISSION?
The process of gliotransmission has been defined as analogous to
neurotransmission, except that the source of the transmitters is
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glia (i.e., astrocytes) rather than neurons (Volterra and Meldolesi,
2005). The other properties are essentially the same: a fast, Ca2+-
dependent exocytosis of transmitters resulting in stimulation of
synaptic receptors and acute synaptic modulation.
MECHANISMS OF ASTROCYTE Ca2+ ELEVATIONS
It is first important to point out that there is no firm definition
of an astrocyte. If the definition is exclusively morphological, i.e.,
highly ramified star-shaped cells, then the so-called “complex” glia
could be included as an astrocyte subtype (see Nishiyama et al.,
2005). This broad classification results in considerable hetero-
geneity in the astrocyte population and can be problematic when
considering sources of Ca2+ elevations in astrocytes. Complex
glia, so named because of their complex current pattern evoked
using voltage-step protocols, have also been referred to as GluR
cells due to their expression of functional ionotropic glutamate
receptors (iGluRs; Matthias et al., 2003; Jabs et al., 2005). Evi-
dence suggests that the AMPA iGluRs expressed by complex glia
and Bergmann glia of the cerebellum are of the Ca2+-permeable
variety, thereby providing a source for fast focal Ca2+ elevations
in these cells (Lin and Bergles, 2004; Lin et al., 2005; Piet and Jahr,
2007; Hamilton et al., 2010). In developing brain tissue, complex
glia also include immature passive astrocytes (Walz, 2000; Zhou
et al., 2006), but in the mature brain they appear to be a unique
cell population called NG2+ glia due to their surface expression
of NG2 proteoglycan. NG2+ glial cells have a star-shaped mor-
phology and do not fire action potentials, but otherwise differ
from the subpopulation of mature passive astrocytes in nearly
every other way (reviewed in Lin and Bergles, 2002). Importantly,
there is little convincing evidence to date that passive astrocytes in
intact tissue express neurotransmitter-gated ionotropic receptor
types that could provide a source for fast local Ca2+ elevations.
Because of these differences, inclusion of complex glia or special-
ized astrocytes such as Bergmann glia in the sampled population
of “astrocytes”could lead to very different conclusions about astro-
cyte signaling properties. In this review, for clarity our definition
of astrocyte includes the protoplasmic passive subtype only, which
are the glial fibrillary acidic protein (GFAP)-expressing glial cells
that express glutamate transporters, are coupled by gap junctions,
and whose processes envelop synapses and form endfeet on the
cerebrovasculature.
In addition to lacking Ca2+-permeable ligand-gated ion chan-
nels, there is also evidence that astrocytes do not express voltage-
gated calcium channels (VGCCs; Carmignoto et al., 1998),
although the expression of VGCCs in passive astrocytes may still
be a matter of debate. We have assayed for functional expression of
astrocytic VGCCs as well by applying strong trains of depolarizing
stimuli via whole-cell patch pipette (Figure 1). The depolarizing
stimuli did not evoke Ca2+ elevations anywhere in the astrocyte,
which nevertheless exhibited spontaneous Ca2+ elevations and
responded to bath application of a cocktail of agonists to endoge-
nous Gq GPCRs. In summary, it does not appear that astrocytes
possess a fast source of Ca2+ elevations capable of responding to
neuronal inputs on a millisecond timescale. This also distinguishes
gliotransmission from neurotransmission, which is triggered by
the rapid gating of presynaptic VGCCs located adjacent to a readily
releasable pool of synaptic vesicles.
The source of astrocyte Ca2+ elevations appears to be almost
exclusively Gq GPCR activated, inositol 1,4,5-triphosphate recep-
tor (IP3R)-sensitive intracellular stores, involving the canonical
phospholipase C (PLC)/IP3 pathway. Upon Gq GPCR activation,
PLC hydrolyzes the membrane lipid phosphatidylinositol 4,5-
bisphosphate (PIP2) to generate diacylglycerol (DAG) and IP3,
leading to IP3R activation and Ca2+ release from the endoplas-
mic reticulum (ER). The lines of evidence for Gq GPCR-mediated
Ca2+ sources in astrocytes are multiple. First, there is strong
evidence that astrocytes express Gq GPCRs for endogenous neuro-
transmitters (Porter and McCarthy, 1997) that can be activated by
bath application of various agonists (e.g., Shelton and McCarthy,
2000). Second, Ca2+ elevations evoked by neuronal afferent stim-
ulation in situ or by sensory stimulation in vivo are significantly
inhibited by application of specific Gq GPCR antagonists (Porter
and McCarthy, 1996; Perea and Araque, 2005; Wang et al., 2006).
Third, spontaneous astrocytic Ca2+ transients are inhibited by the
G-protein inhibitor GDP-βs, the IP3R antagonist heparin, or by
depletion of internal Ca2+ stores using thapsigargin (Nett et al.,
2002; Di Castro et al., 2011). Last, spontaneous and evoked astro-
cyte Ca2+ elevations are almost completely abolished by removal
of the astrocyte-specific IP3R, the IP3R type 2 (IP3R2; Petravicz
et al., 2008; Agulhon et al., 2010; Di Castro et al., 2011; Takata
et al., 2011; Navarrete et al., 2012). Interestingly, one study has
reported small residual and infrequent Ca2+ elevations remaining
in astrocytic fine processes in IP3R2 knockout mice (Di Castro
et al., 2011). The source of these Ca2+ elevations remains to be
determined, but they may be Gq GPCR-independent and play a
role in setting basal or resting Ca2+ levels in astrocytes (see below).
Nevertheless, taken together the above evidence indicates that both
evoked and spontaneous Ca2+ elevations in astrocytes are driven
almost exclusively by Gq GPCR-coupled release from intracellular
stores.
ARE ASTROCYTIC Gq GPCR-MEDIATED Ca2+ ELEVATIONS SUFFICIENT
TO INDUCE GLIOTRANSMITTER RELEASE?
Early work demonstrating gliotransmission in astrocyte-neuron
co-cultures provided evidence that Ca2+ was “necessary and suf-
ficient” for this process (Araque et al., 1998, 1999; Parpura and
Haydon, 2000). Around this same period of time the emerging
evidence that astrocytes in situ expressed numerous Gq-coupled
metabotropic receptor types that could be activated by neuronal
activity set the stage for the concept of gliotransmission; i.e.,
that spillover of synaptically released neurotransmitter stimulates
astrocytic Gq GPCR signaling cascades, resulting in astrocytic
Ca2+ elevations that reciprocally and acutely modulate synap-
tic transmission through release of gliotransmitters (Volterra and
Meldolesi, 2005; Halassa et al., 2007). More recent work has called
into question the Ca2+-dependency of gliotransmission. To test
the hypothesis that physiologically relevant astrocyte Ca2+ eleva-
tions results in gliotransmission required that astrocytic Gq GPCRs
actually be stimulated. This was problematic in intact tissue since
bath application of Gq GPCR agonists such as the group I mGluR
agonist DHPG directly stimulates metabotropic glutamate recep-
tors (mGluRs) on both astrocytes and neurons as well as other
cell types including microglia (Pocock and Kettenmann, 2007;
Farso et al., 2009). Therefore, transgenic tools were developed to
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FIGURE 1 | Passive astrocytes do not express functional
voltage-gated calcium channels. (A) Astrocytes in stratum radiatum of
acute hippocampal slices were patch-clamped with a small pipette tip
(7–9 MΩ) in order to limit dialysis of the pipette contents during the
recording. Included in the pipette was 150µM of the cell impermeant Ca2+
indicator Oregon Green BAPTA-1 (OGB-1). (B) Passive mature astrocytes
were characterized by the absence of voltage-gated currents evoked by a
voltage-step protocol (−180 to +80 mV in 20 mV increments). (C) In 6/10
astrocytes from 10 slices, despite whole-cell voltage clamp the astrocytes
exhibited spontaneous Ca2+ elevations (arrows) and evoked Ca2+
responses to an agonist cocktail consisting of 10µM each of the Gq GPCR
agonists histamine, carbachol, and ATP. However, strong depolarizing
trains (−90 to 0 mV at 1 Hz for 10 or 50 s) through the patch pipette did not
produce any increases in fluorescence, indicating a lack of voltage-gated
Ca2+ channels in astrocytes. The remaining 4/10 astrocytes did not respond
to depolarization or agonist cocktail with Ca2+ elevations, but did respond
to agonist cocktail after pipette removal. This is presumably an effect of
dialysis of the cell by the whole-cell recording pipette.
selectively stimulate or eliminate astrocytic Gq GPCR-mediated
Ca2+ elevations (Fiacco et al., 2007; Petravicz et al., 2008; Agul-
hon et al., 2010). Surprisingly, selective stimulation or removal
of astrocyte Gq GPCR-mediated Ca2+ elevations had no effect
on CA1 pyramidal neuron excitatory synaptic transmission and
hippocampal short- and long-term plasticity (LTP). These find-
ings suggested that astrocyte Ca2+ elevations are not sufficient for
gliotransmission in acute hippocampal slices. The results of these
studies have already been well-documented as they have led to
considerable debate as to whether the mechanisms of gliotrans-
mission, as they have been conceived, are physiologically relevant
(Kimelberg, 2007; Hamilton and Attwell, 2010; Kirchhoff, 2010;
Smith, 2010).
What could be the source of activity-induced astrocyte Ca2+
elevations responsible for gliotransmission then, if it is not from
iGluRs, VGCCs, or Gq GPCRs? It has been recently pointed out
that, due to the tiny size of fine astrocyte processes (20–30 nm)
surrounding synapses, the relevant Ca2+ elevations involved in
gliotransmission may be too small, too fast, and too local to detect
using available Ca2+ indicators and two-photon imaging methods
(Rusakov et al., 2011). However, these putative Ca2+ sources would
not likely include Gq GPCRs/IP3Rs, as the 20- to 30-nm, thin
sheet-like processes of astrocytes frequently surrounding synapses
are most often devoid of ER (Peters et al., 1991). Furthermore,
numerous reports have provided evidence to suggest that only
very large astrocyte Ca2+ elevations evoked using strong afferent
stimulation of multiple inputs or uncaging of IP3 or Ca2+ may be
sufficient to release sufficient gliotransmitter from diffusely scat-
tered synaptic-like microvesicles to overcome reuptake by astro-
cytic and neuronal transporters to stimulate neuronal receptors
(Fiacco and McCarthy, 2004; Takata et al., 2011; Navarrete et al.,
2012). A more intriguing possibility is that gliotransmitter release
is dependent on other signaling molecules produced by activated
microglia and reactive astrocytes in addition to astrocyte Ca2+
(e.g., Santello et al., 2011), as will be discussed further below.
Additional evidence questioning Ca2+-dependent release of
gliotransmitters by astrocytes in healthy brain tissue is the lack
of propagating intercellular astrocyte Ca2+ waves. The original
report of intercellular astrocyte Ca2+ waves in cultured astro-
cytes created quite a bit of excitement as it was postulated as a
mechanism for long-distance signaling in the brain by an other-
wise electrically non-excitable cell type (Cornell-Bell et al., 1990).
Later work revealed that the mechanism underlying this phe-
nomenon is release of the gliotransmitter ATP, which binds P2Y
www.frontiersin.org July 2012 | Volume 3 | Article 139 | 3
Agulhon et al. Gliotransmission in normal vs. reactive astrocytes
purinergic Gq GPCRs on adjacent astrocytes resulting in Ca2+
liberation from internal stores, ATP release, and thus wave regen-
eration and propagation (Cotrina et al., 2000; Arcuino et al., 2002;
Bowser and Khakh, 2007). Propagating glial Ca2+ waves have
also been observed in the white matter of neonatal brain tissue
(Schipke et al., 2002) and in the retina (Newman, 2001), but
not in cortical gray matter astrocytes in situ or in vivo (Fiacco
and McCarthy, 2006; Kuchibhotla et al., 2009). We have per-
formed additional experiments to assay for Ca2+wave propagation
between astrocytes using acute hippocampal slices from transgenic
mice in which a large percentage of astrocytes selectively express
the MrgA1 Gq GPCR (Fiacco et al., 2007; Figure 2). The design
of these experiments is very simple: astrocytes were bulk-loaded
with Ca2+ indicator and the MrgA1 receptor agonist FMRF and
the group I mGluR agonist DHPG were applied in succession.
Most astrocytes respond with characteristic long duration Ca2+
elevations to both agonists, but occasionally there are astrocytes
that respond only to one agonist but not the other. Response to
one agonist serves as a positive control that the astrocytes are
viable. This is evidence against Ca2+-dependent release of ATP
by astrocytes, because it is expected that astrocytes not expressing
the MrgA1R or group I mGluRs would also have Ca2+ eleva-
tions due to the high amounts of ATP being released by the
surrounding astrocytes. These data suggest that the only astro-
cytes capable of producing Ca2+ elevations are those cells that
express the Gq GPCR being stimulated by the bath-applied ago-
nist. It should be pointed out that cells expressing MrgA1R Ca2+
responses have been electrophysiologically confirmed as passive
astrocytes in 100% of cases (n> 50 cells; unpublished observa-
tions). In summary, the propagating intercellular Ca2+ wave is
clear evidence for astrocytic release of gliotransmitters, evidence
which is lacking in astrocytes from healthy tissue in situ or in vivo.
However, as will be discussed below, in the diseased or damaged
brain propagating astrocytic Ca2+ waves are evident, suggesting
that changes occurring in reactive astrocytes are permissive for
gliotransmitter release.
BASAL (RESTING) Ca2+ VS. ACTIVITY-EVOKED Ca2+ ELEVATIONS
Many studies concluding a role for gliotransmission have used the
Ca2+ chelators BAPTA and/or EGTA in an effort to block astrocytic
Gq GPCR Ca2+ elevations. These manipulations have produced
clear effects on neuronal activity, suggesting that activity-induced
astrocyte Ca2+ elevations modulate neuronal activity by gliotrans-
mission. It has been difficult to reconcile these findings with those
using IP3R2 knockout mice, in which astrocytic Gq GPCR Ca2+
elevations are also abolished but without a corresponding effect
on hippocampal excitatory synaptic activity or NMDA receptor-
dependent LTP (for example, compare Agulhon et al., 2010 with
Henneberger et al., 2010). Exciting new work has provided a
potential explanation for this discrepancy (Shigetomi et al., 2012).
Using a membrane-tethered genetically encoded Ca2+ indicator
(Lck-GCaMP3), spotty Ca2+ signals were observed in cultured
astrocytes that were not dependent on Ca2+ release from internal
stores. Rather, these signals seemed to be dependent on extra-
cellular influx of Ca2+ through transient receptor potential A1
(TRPA1) channels on the astrocyte membrane. These fast, focal
Ca2+ elevations were shown to contribute to, and set resting
Ca2+ levels in astrocytes. Could these channels represent the
Ca2+ source required for gliotransmission? It cannot be ruled
out; however, they seemed to open in an activity-independent
manner and affect synaptic activity in hippocampal interneurons
by a mechanism other than gliotransmission, i.e., by regulating
FIGURE 2 | Propagating intercellular Ca2+ waves are unlikely to occur
between astrocytes in acute hippocampal slices from healthy brain.
Astrocytes in stratum radiatum of hippocampal slices from MrgA1 Gq GPCR
transgenic mice were bulk-loaded with Ca2+ Green 1-AM indicator dye as
described previously (Fiacco et al., 2007; left panel). Boxed regions of interest
over individual astrocyte somata match numbered Ca2+ traces (right panel).
Stimulation with either 10µM FMRF or 50µM DHPG evoked Ca2+ elevations
in 56/75 (75%) or 67/75 (89%) of astrocytes, respectively, through activation
of MrgA1Rs or group I mGluRs (n= 9 slices). In total, 50/75 (67%) of
astrocytes responded to both agonists. However, 24/75 (32%) of astrocytes
responded to one, but not the other, agonist. These results suggest that
despite strong Ca2+ elevations in many astrocytes, the gliotransmitter ATP is
not released in sufficient quantity to stimulate purinergic P2Y Gq GPCRs on
adjacent astrocytes.
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the functional expression of astrocytic GABA transporters at the
plasma membrane. It will be interesting in future work to deter-
mine if activity-independent Ca2+ influx setting basal Ca2+ levels
is important for tonic release or uptake of gliotransmitters to set
ambient concentrations of ATP/adenosine, d-serine, or glutamate
(Jabaudon et al., 1999; Cavelier and Attwell, 2005; Cavelier et al.,
2005; Le Meur et al., 2007). Together, these findings suggest that
caution should be exercised in the interpretation of experiments
dialyzing the astrocytic syncytium with Ca2+ chelators such as
BAPTA and/or EGTA, which will not only block activity-induced
Gq GPCR Ca2+ elevations but also clamp resting Ca2+ levels.
QUESTIONABLE TIMING FOR GLIOTRANSMISSION TO ACUTELY
MODULATE SYNAPTIC TRANSMISSION: ASTROCYTES AS
GLIOMODULATORS OR “RE-SUPPLIERS”
In order for gliotransmission to reciprocally affect synaptic events
occurring on a millisecond timescale, it needs to occur along
a similar timescale. As discussed above, evidence to date indi-
cates that metabotropic Gq GPCRs are the prevailing mechanism
behind activity-induced astrocytic Ca2+ elevations. Because the
pathway to Ca2+ elevations involves a metabotropic signaling
cascade, there is a considerable delay between neurotransmitter
binding the receptor and the ensuing Ca2+ response. In our own
recordings at room temperature in acute hippocampal slices, the
time interval – on average – between a 50-Hz train of Schaffer
collateral stimulation and the first responsive astrocytic com-
partment (almost always a small to medium-sized process) is 8 s
(Figures 3A,C,E). This of course, is an average, and there may be
some small compartments and/or a small subset (5%) of astro-
cytes capable of faster responses (Winship et al., 2007; Panatier
et al., 2011). The remaining astrocytic compartments (encompass-
ing the vast majority of the cell volume) take longer to respond
due to the slow intracellular wave propagation rate of astrocyte
Ca2+ (5–15µm/s;Yagodin et al., 1994; Fiacco and McCarthy, 2006;
Fiacco et al., 2007). Some of the delay to the initial astrocyte Ca2+
response can be attributed to the kinetics of the Ca2+ indica-
tor dye converting the binding of Ca2+ to a fluorescence signal
and to the spatial and temporal resolution of optical detection,
but this can be taken into account by recording neuronal Ca2+
signals using the same fluorescence indicator and microscope set-
tings. In contrast to astrocytic Ca2+ elevations, neuronal Ca2+
elevations using the same settings appear to occur instantaneously
(Figures 3B,D,E). In the same preparation and in the same condi-
tions, the delay to evoke excitatory field potentials (fEPSPs) from
a single depolarizing pulse to the Schaffer collaterals is ∼5 ms,
while whole-cell NMDA receptor-mediated eEPSCs are evoked
after∼4 ms (Figure 3F). Calcium elevations in the dendritic spines
due to NMDA receptor activation are detected a little over 10 ms
after photolysis of extracellular caged glutamate (Bloodgood and
Sabatini, 2007), while elevations in the proximal dendrites gener-
ated by the opening of VGCCs gated by back-propagating action
potentials occur within 100–200 ms (Fedirko et al., 2007). There-
fore, detection issues cannot account for slow Ca2+ response times
of astrocytes. Recording at room temperature will also slow down
astrocyte Ca2+ response times, since the activity rates of effector
proteins and enzymes in the Gq GPCR signaling cascade will be
reduced compared to physiological temperature. However, even
in vivo, astrocyte cell bodies respond to sensory or motor stimula-
tion after a delay of ∼2–10 s, with Ca2+ increases in the processes
occurring ∼1 s earlier than those in the soma (Wang et al., 2006;
Dombeck et al., 2007; Schummers et al., 2008; Navarrete et al.,
2012). Overall, the bulk of the evidence indicates that activity-
induced astrocytic Gq GPCR Ca2+ responses in processes occur
on a timescale of seconds. This is a 1000-fold slower than synaptic
responses.
Now, as an example, we will consider this timing in the context
of release of the gliotransmitter d-serine by astrocytes. d-serine is
a required co-agonist of the NMDA receptor – without d-serine
bound the NMDA receptor ion channel cannot open (Johnson
and Ascher, 1987; Mothet et al., 2000). The complete cycle of
d-serine synthesis, release, uptake, and enzymatic breakdown is
not yet fully understood, but most evidence suggests that there
are high – although not completely saturating – concentrations of
extracellular d-serine in most forebrain areas (Miller, 2004; Verrall
et al., 2010). This leaves room for activity-dependent modula-
tion of NMDA receptor function by regulated release of d-serine.
For the sake of this discussion we must first assume that astro-
cytes are capable of producing and secreting d-serine, which has
recently come under question. d-serine was originally thought
to be produced and secreted only by astrocytes due to astrocyte-
specific expression of the synthesizing enzyme serine racemase
(SR; Wolosker et al., 1999). More recent data using different anti-
bodies to SR and selective knockout studies suggest that SR is a
neuronal enzyme (Kartvelishvily et al., 2006; Miya et al., 2008;
Benneyworth et al., 2012). The recent study by Benneyworth et al.
(2012) does suggest that a small portion of extracellular d-serine
might be supplied by astrocytes.
Activity-dependent release of d-serine by astrocytes has been
reported to be required for hippocampal LTP as well as LTP of
local field potentials in the somatosensory cortex (Henneberger
et al., 2010; Takata et al., 2011). The idea is that spillover of
glutamate or glutamate+ acetylcholine (ACh) from repetitive
stimulation of neuronal afferents activates astrocytic mGluRs
or mGluRs+metabotropic ACh receptors (mAChRs) to trig-
ger Ca2+-dependent d-serine release from astrocytes, which is
then necessary for postsynaptic NMDA receptor activation and
LTP. However, if we walk through the steps in this process it
becomes evident that the timing is problematic (Figure 4 – for
simplicity only hippocampal NMDA receptor-mediated LTP is
depicted). First, presynaptically released glutamate during the
high-frequency stimulus (HFS) train crosses the narrow (20 nm)
synaptic cleft and binds postsynaptic NMDA and AMPA receptors.
In approximately 4–5 ms these channels open and pass postsynap-
tic current, and postsynaptic Ca2+ increases via entry through
the NMDA receptor channel are observed after 10 ms (Bloodgood
and Sabatini, 2007). Within 100–200 ms, Ca2+ is already elevating
in the proximal apical dendrites due to back-propagating action
potentials (Fedirko et al., 2007). During the HFS train the concen-
tration of glutamate/ACh builds up and spills out of the synapse,
reaching sufficient levels to overcome glutamate clearance or ACh
breakdown to bind and activate astrocytic mGluRs or mAChRs.
The activated Gq GPCRs exchange GDP for GTP and the α and
βγ subunits dissociate. The α subunit then activates the enzyme
phospholipase C (PLC) in the astrocyte membrane. Next, PLC
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FIGURE 3 | Delay between Schaffer collateral stimulation and evoked
astrocyte or neuronal Ca2+ responses and AMPA and NMDA receptor
currents. (A,C) Astrocyte in stratum radiatum (A) and CA1 pyramidal
neuron (B) each filled with 150µM OGB-1 Ca2+ indicator dye. Boxed
regions of interest in subcellular compartments correspond to the
fluorescence traces in (C,D). Boxes were placed all over the visible
astrocyte but only a few are shown for clarity. Cells were given 10 min to
recover after removal of the whole-cell patch clamp pipette prior to
Schaffer collateral stimulation. The stimulating electrode was placed 75µm
from the recorded cells. (C,D) Schaffer collateral stimulation at 50 Hz for 1s
produced astrocytic Ca2+ elevations after ∼3 s in the first responding
process of this specific astrocyte (C), while neuronal Ca2+ elevations
occurred almost instantaneously in proximal neuronal compartments in
this example as well as all other recorded neurons (n=4) (D). (E)
Astrocyte Ca2+ elevations occurred on average after ∼8 s in the first
responding compartment (n=4 cells). Response initiation times were
defined as the first data point that preceded two successive data points
that were ≥3 S.D. above the mean baseline noise. We have observed that
the astrocytic Ca2+ responses to the first stimulation are faster and more
reliable than subsequent stimulations, so only the responses to the first
stimulation were calculated. (F) In the same conditions, fEPSPs (n=5
slices) and whole-cell CA1 neuronal NMDA eEPSCs (n=16 cells, 16 slices)
were evoked after ∼5 and 4 ms, respectively, in response to single
depolarizing pulses (0.05 Hz) to the Schaffer collaterals.
mediates the conversion of inositol bisphosphate (PIP2) to IP3 and
diacylglycerol (DAG). IP3 builds up in the astrocytic cytosol and
binds its target receptor, IP3R2, on the ER. Activation of the IP3R2
results in channel opening and Ca2+ efflux from the ER into the
cytosol, detected by the fluorescence indicator a few seconds after
neuronal afferent stimulation. The locally elevated Ca2+ propa-
gates into adjacent astrocytic compartments including the 20- to
30-nm sheet-like processes frequently surrounding synapses at a
rate of 5–15µm/s, where it encounters along the way small and
diffuse synaptic-like microvesicles which are triggered to exocytose
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and release d-serine into the extrasynaptic space. The extracel-
lular d-serine presumably reaches a sufficient concentration to
percolate back into the synapse to bind synaptic NMDA receptors,
permitting NMDA receptor channels to open to pass current and
elevate postsynaptic Ca2+.
The obvious problem with this scenario is that the requirement
for astrocytic d-serine as a necessary co-agonist at the NMDA
receptor occurred a 1000 times earlier in relative synaptic time
(Figure 4). This scenario does not take into account the rise time
of astrocyte Ca2+ elevations, which is often seconds long (Wang
et al., 2006; Henneberger et al., 2010; Navarrete et al., 2012).
The very observation that NMDA receptor currents are evoked
in ∼4 ms and postsynaptic Ca2+ elevates shortly thereafter indi-
cates that the d-serine required for NMDA channel opening was
already available, as suggested by the relatively high ambient d-
serine levels in the synapse (Mothet et al., 2000). The remaining
activity-dependent release of d-serine may come from the presy-
naptic or postsynaptic neuronal compartments, as reported in a
recent study (Rosenberg et al., 2010). The advantage provided by
this mechanism is that ambient and activity-induced release of
d-serine will be available as a required co-agonist at the same
time that presynaptically released glutamate is binding the NMDA
receptor. Astrocytes, known to maintain ionic and neurotransmit-
ter homeostasis (Kimelberg, 2007), might instead participate in
setting ambient d-serine levels in a manner dependent on rest-
ing Ca2+. In this context, it seems conceivable that reducing or
clamping resting Ca2+ levels in astrocytes using intracellular Ca2+
chelators minutes before HFS could decrease overalld-serine levels
and LTP. Such a hypothesis, if validated, could reconcile discrep-
ancies between studies (Agulhon et al., 2010; Henneberger et al.,
2010).
Because of the slow timing of metabotropic receptor-evoked
astrocyte Ca2+ elevations, astrocytes seem to be more optimally
suited to modulate subsequent neuronal activity or play a role
as “re-suppliers” as opposed to acute modulators. Is this glio-
transmission? Arguably not, based on the current definition of
gliotransmission. The term “gliomodulation” may be more appro-
priate and better distinguish this process from neurotransmission.
Interestingly, Rosenberg et al. (2010) found that extracellular
d-serine is reduced minutes after its initial increase following
neuronal depolarization. Astrocyte Ca2+ may then participate in
re-setting ambient levels of d-serine following depletion through
repetitive neuronal activity. Astrocytes as re-suppliers can also be
considered in the case of cerebrovascular coupling. As this process
is also thought to be regulated by activity-induced astrocyte Gq
GPCR Ca2+ (Simard et al., 2003; Zonta et al., 2003; Mulligan
and MacVicar, 2004), astrocytes are well-positioned to re-supply
neurons with metabolites and oxygen after these substrates are
depleted during repetitive neuronal activity.
EVIDENCE SUPPORTING Ca2+-DEPENDENT
GLIOTRANSMITTER RELEASE IN THE EARLY STEPS OF THE
INFLAMMATORY PROCESS AND IN THE DISEASED OR
DAMAGED BRAIN
REACTIVE ASTROCYTES
In the previous section we discussed evidence questioning the exis-
tence of gliotransmission in healthy brain tissue. In this section we
will review data suggesting that activated microglia and reactive
astrocytes engage in a partnership for Ca2+-dependent gliotrans-
mitter release. First, what is a reactive astrocyte? Reactive astrocytes
or reactive astrogliosis can be defined as a graded progression of
molecular, cellular, and functional changes that range from sub-
tle alterations in gene expression to glial scar formation (Hamby
and Sofroniew, 2010). Reactive astrocytes are a hallmark of nearly
all brain pathologies, including traumatic brain injury, stroke,
ischemia, infectious disease, neuroinflammatory and neurodegen-
erative disease, epilepsy, brain tumors, and possibly even more
subtle disorders such as schizophrenia, migraine, and depression.
The list of changes that have been documented to occur in reac-
tive astrocytes is extensive, and includes hypertrophy (Sofroniew,
2009), upregulated expression of GFAP (Pekny and Nilsson, 2005),
altered expression of: mGluRs (Aronica et al., 2003), glutamate
transporters and glutamine synthetase (Pardo et al., 2006; Ortin-
ski et al., 2010), ephrins and their receptors (Goldshmit et al.,
2006), aquaporin-4 (AQP4) and potassium channels (Binder and
Steinhauser, 2006), and production and secretion of inflammatory
molecules (e.g., TNFα, SDF-1α, PGE2) and oxygen free radicals
(Lucas et al., 2006; Peng et al., 2006; Farina et al., 2007; Brambilla
et al., 2009; Steele and Robinson, 2012).
One of the persistent problems in understanding astrocytic
involvement in progression of changes occurring in the diseased
or damaged brain is establishing cause-and-effect relationships. It
seems that research is beginning to move past cataloging changes
that are present in damaged tissue to carefully examining the initial
sequence of events occurring in the progression of disease before
overt neuroanatomical changes or onset of behavioral symptoms
(Colangelo et al., 2012). Accumulating evidence is suggesting that
microglia, the brain’s resident immune cells, are activated first, and
through release of ATP and inflammatory mediators including
interleukin-1 (IL-1), TNFα, or PGE2, subsequently trigger astro-
cytic activation (Bezzi et al., 2001; Ikeda-Matsuo et al., 2005; Liu
et al., 2011; Machado et al., 2011; Colangelo et al., 2012; Pascual
et al., 2012). Activated (reactive) astrocytes then increase their
production and secretion of SDF-1α (Bajetto et al., 1999; Peng
et al., 2006), TNFα, and/or PGE2 (Bezzi et al., 2001; Alvarez et al.,
2010) which, in conjunction with Ca2+, promotes gliotransmitter
(ATP, glutamate) release. All of these molecules may act in concert
through complex autocrine/paracrine or astrocyte-microglial sig-
naling pathways to generate and amplify propagating intercellular
astrocyte Ca2+ waves and increase neuronal excitability (Bajetto
et al., 1999; Cotrina et al., 2000; Bezzi et al., 2001; Han et al., 2001;
Arcuino et al., 2002; Domercq et al., 2006; Bowser and Khakh,
2007; Santello et al., 2011; Pascual et al., 2012). These events are
initiated rapidly, within seconds to minutes, suggesting that they
may be among the early events underlying excitotoxic damage in
disorders and diseases of the central nervous system.
PROPAGATING INTERCELLULAR Ca2+ WAVES
As discussed above, evidence for intercellularly propagating Ca2+
waves among cortical gray matter astrocytes in healthy brain tis-
sue in situ or in vivo is lacking (Fiacco and McCarthy, 2006;
Kuchibhotla et al., 2009). On the contrary, dramatic changes in
astrocytic Ca2+ homeostasis have been observed under patholog-
ical conditions (e.g., epilepsy or Alzheimer’s disease) in situ and
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FIGURE 4 |Time course of synaptic mechanisms leading to the
induction of NMDA receptor-mediated LTP vs. time course of
activity-evoked Gq GPCR Ca2+-mediated D-serine release from
astrocytes in CA1 hippocampus: millisecond timescale mechanisms vs.
second timescale mechanisms. Left panel, Induction of LTP requires: (i)
High-frequency presynaptic stimulation (HFS) to release the
neurotransmitter glutamate – beginning of HFS is noted as 0 ms time point;
(ii) Depolarization of the postsynaptic compartment by glutamate-mediated
AMPA receptor activation allowing Mg2+ block relief of the NMDA receptors,
and activation of NMDA receptors by glutamate and necessary co-agonist
D-serine (4–5 ms time points); (iii) Ca2+ entry through NMDA receptor
channel (10 ms time point). This resulting rise in Ca2+ is crucially important to
the induction of LTP and may be amplified by concurrent activation of
VGCCs. At 100–200 ms time point, Ca2+ is elevating in the proximal apical
dendrite due to back-propagating APs that might act as a retrograde signal
to modulate LTP to some extent. All of these steps happen over a timescale
of milliseconds and are represented in green. Right panel, HFS-evoked
release of D-serine from astrocytes requires: (i) Spillover of presynaptically
released glutamate from the synapse, reaching sufficient levels to overcome
glutamate clearance by neuronal and astrocytic glutamate transporters; (ii)
Glutamate binding and activation of astrocytic mGluRs on astrocyte
processes enveloping synapses, which leads to PLC-mediated formation of
IP3; (iii) Ca2+ release from ER upon IP3R2 receptor channel activation by IP3
binding (1–8 s time point – represented in blue). Note that in the astrocyte
sheet-like processes surrounding synapses that are frequently 20–30 nm
thick, the presence of ER might be limited and the IP3 must diffuse into
thicker astrocyte processes where ER components are more likely present;
(iiii) Intercellular Ca2+ wave propagation (5–15µm/s) that triggers exocytosis
of the sparse D-serine containing synaptic-like vesicles encountered along
the way. In this context, activity-evoked D-serine release from astrocytes
occurs in a second timescale after the beginning of HFS and therefore
cannot be the source of the required co-agonist necessary for NMDA
receptor activation, which occurs within 4–5 ms. Activity-induced and Gq
GPCR Ca2+-mediated release of D-serine from astrocytes seems to be more
optimally suited to modulate subsequent neuronal activity (i.e., involving
gliomodulation as opposed to acute “gliotransmission”) or plays a role to
“re-supply” ambient levels of extracellular D-serine, which is partially
depleted through HFS. Abbreviations: AP, action potential; α, Gq α subunit;
βγ, Gq βγ subunits; ER, endoplasmic reticulum; IP3, inositol
1,4,5-triphosphate; IP3R2, astrocyte-specific IP3 receptor type 2; LTP,
long-term potentiation; PIP2, inositol bisphosphate; PLC, phospholipase C;
VGCC, voltage-gated Ca2+ channel.
in vivo, affecting the frequency, duration, and amplitude of astro-
cytic Ca2+ transients (Aguado et al., 2002; Hirase et al., 2004;
Kuchibhotla et al., 2009). Powerful astrocytic intercellular Ca2+
waves were found to travel across the cortex in a mouse model
of Alzheimer’s disease in vivo but not in wild type littermates
(Kuchibhotla et al., 2009), suggesting that Ca2+ waves signal the
existence of a pathological insult, as previously postulated (Fiacco
and McCarthy, 2006; Scemes and Giaume, 2006). Long-distance
and tetrodotoxin-insensitive astrocytic intercellular Ca2+ waves
have also been described in spreading depression (Basarsky et al.,
1998; Kunkler and Kraig, 1998; Peters et al., 2003; Chuquet et al.,
2007), which is believed to occur in several neurological disorders
including migraine (Hadjikhani et al., 2001; James et al., 2001),
trauma (Fabricius et al., 2006), and stroke (Strong et al., 2002;
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Dreier et al., 2006; Fabricius et al., 2006), contributing to the death
of compromised tissue (Busch et al., 1996; Nedergaard, 1996). In
summary, in the diseased or damaged brain propagating astrocytic
Ca2+ waves are evident, suggesting that changes occurring in reac-
tive astrocytes may be permissive for Ca2+-dependent release of
gliotransmitters (ATP).
REQUIREMENT OF ACTIVATED MICROGLIA, REACTIVE ASTROCYTES
AND INFLAMMATORY MOLECULES, AND POTENTIAL FOR
THERAPEUTIC INTERVENTION
An intriguing possibility conferring pathological relevance to
astrocytic release of gliotransmitters is that this process is actu-
ally dependent on other signaling molecules produced by acti-
vated microglia and reactive astrocytes in addition to Ca2+. A
new report supports this hypothesis by showing that activated
microglia recruit astrocytes to modulate neuronal activity early
in the inflammatory process (Pascual et al., 2012). Activation
of microglia using a proinflammatory toll-like receptor 4 ligand
(TLR4), lipopolysaccharide (LPS), induced a rapid (within min-
utes) and transient (∼10 min-long) increase in the frequency of
excitatory synaptic events in acute hippocampal slices. The mech-
anism for this effect involved the release of ATP by microglia
to activate metabotropic P2Y1 receptors (P2Y1Rs) on astrocytes,
triggering glutamate release from astrocytes to modulate synaptic
mGluRs. Because activation of microglia and alteration of neuro-
transmission are two early symptoms of most brain diseases, these
findings support the idea that activated microglia are an upstream
partner of astrocytes that transforms astrocytes into glutamate
releasing cells, which may contribute to the initiation of burst-
ing neuronal activity in the epileptic brain (Pascual et al., 2012)
or other neurological disorders. Remarkably, the inflammatory
mediators TNFα and PGE2 can also be co-released downstream of
astrocytic ATP-induced P2Y1R activation, dramatically enhanc-
ing glutamate release from astrocytes, with TNFα action being
a requirement for this glutamate response to occur (Domercq
et al., 2006; Santello et al., 2011); although the requirement of
TNFα is debated (Pascual et al., 2012). Even more striking is the
observation that inflammatory molecules themselves can elicit a
rapid (seconds) astrocytic release of glutamate without involve-
ment of any Gq GPCR stimulation. SDF-1α, TNFα, or PGE2
by themselves are sufficient to induce glutamate release from
astrocytes through selective activation of their respective recep-
tors: Gi/o GPCRs (CXCR4), trimeric TNF receptors (TNFR), or
Gi/Gs GPCRs [prostaglandin E (EP) receptors; Bezzi et al., 1998,
2001; Sanzgiri et al., 1999; Cali et al., 2008]. Although under-
standing of the pathways downstream of CXCR4, TNFR, or EPs
remains largely incomplete in astrocytes, it has been assumed that
selective activation of one of these receptor types is sufficient
to elicit a Ca2+-dependent exocytosis of glutamate from astro-
cytes. This assumption is based mainly on a study suggesting
that CXCR4, TNFR, and EPs participate in the same sequence
of events that ultimately leads to Ca2+-dependent exocytosis of
glutamate, a response otherwise blocked by intracellular Ca2+
chelators or inhibitors of exocytosis (Bezzi et al., 2001). CXCR4
activation induces a complex ensuing signaling cascade involving
extracellular release of TNFα from astrocytes, autocrine/paracrine
TNFα-dependent signaling, PGE2 formation and secretion from
astrocytes, autocrine/paracrine PGE2-dependent signaling, and
finally glutamate release from astrocytes (Bezzi et al., 2001). In
this context, Ca2+ is mobilized from internal stores following
activation of CXCR4 (Zheng et al., 1999; Bezzi et al., 2001; Cali
et al., 2008) and EP receptors (Sanzgiri et al., 1999), includ-
ing Gi GPCR EP3 (Takemiya et al., 2011) and Gs GPCR EP2
receptors (Di Cesare et al., 2006; Hsiao et al., 2007). CXCR4-
or EP-evoked glutamate release from astrocytes induces presy-
naptic NMDA receptor-dependent synaptic potentiation (San-
tello et al., 2011) or postsynaptic/extrasynaptic NMDA receptor-
dependant slow inward currents (Sanzgiri et al., 1999). Inter-
estingly, EP-mediated Ca2+ elevations spread through neighbor-
ing astrocytes as intercellular Ca2+ waves (Sanzgiri et al., 1999),
strongly suggesting that not only glutamate, but also ATP is
released (Cotrina et al., 2000; Arcuino et al., 2002; Bowser and
Khakh, 2007) following EP activation. Notably, SDF-1α-induced
CXCR4-mediated glutamate release is dramatically enhanced in
the presence of reactive microglia, leading to pro-apoptotic neu-
rotoxicity, a mechanism potentially involved in AIDS dementia
complex (Bezzi et al., 2001; Rossi and Volterra, 2009). Not only
astrocytes, but also microglia and neurons express CXCR4 (Tan-
abe et al., 1997; Asensio and Campbell, 1999; Kaul and Lipton,
1999), and activation of this receptor in microglia causes signif-
icant TNFα release. Microglial TNFα would then add to astro-
cytically released TNFα to amplify the release of glutamate from
astrocytes.
The synergistic initiation of signaling transduction pathways
involving microglia and astrocytes suggests that both cell types
and their signaling pathways may be required, in addition to astro-
cytic Ca2+, to trigger the release of glutamate from astrocytes
(Figure 5). The observation that activated microglia or inflamma-
tory mediators cannot only induce, but also substantially amplify
glutamate release from astrocytes confers pathological relevance to
this process. Furthermore, the rapid (seconds to minutes) induc-
tion of these different pathways suggests that they may be critical
early events contributing to initiation of neuronal signaling cas-
cades leading to hyperexcitability, excitotoxicity, and cell death.
Therefore these transduction pathways could be potential tar-
gets for therapy of multiple neurological, neuroinflammatory, and
neurodegenerative disorders, including stroke, trauma, epilepsy,
Alzheimer’s disease, Huntington’s disease, AIDS dementia com-
plex, and amyotrophic lateral sclerosis. These and a growing list of
other neurological disorders are now understood to share the final
common destructive metabolic pathway of excitotoxicity, which is
an excessive activation of neuronal glutamatergic receptors and
associated signaling molecules (Shaw, 1993; Lau and Tymian-
ski, 2010). Additionally, activated/reactive microglia and astro-
cytes, and production of inflammatory mediators is also another
common element in most, if not all, neurological, neuroinflam-
matory, and neurodegenerative disorders (Lucas et al., 2006).
Glial inflammatory transduction pathways leading to astrocytic
Ca2+-dependent glutamate release could contribute to excitotox-
icity, providing a new framework for elucidating the mechanistic
basis of excitotoxicity and potentially improving upon existing
medications.
Interestingly, in the inflammatory process involving acti-
vated microglia and reactive astrocytes, glutamate release from
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FIGURE 5 | Synergistic signaling transduction pathways involving
activated microglia and reactive astrocytes and their inflammatory
mediators that, in addition to astrocytic Ca2+, may induce the release of
gliotransmitters (glutamate, ATP) in the early steps of the inflammatory
process and in the diseased or damaged brain. ATP, LPS, and/or SDF-1α
are produced following acute and chronic pathological insults to the central
nervous system, e.g., hypoxia, ischemia, epilepsy-associated seizures,
mechanical injury and trauma, or infection (Bajetto et al., 2001; Bodin and
Burnstock, 2001; Cook and McCleskey, 2002; Rivest, 2003; Qin et al., 2005).
These mediators activate microglial purinergic receptors (P2Y12R, P2X4R;
Haynes et al., 2006; Ohsawa and Kohsaka, 2011), TLR4 or CXCR4 as well as
astrocytic CXCR4. Activated microglia then release ATP and/or TNFα to
recruit astrocytes. In astrocytes, binding of ATP and SDF-1α – alone or in
concert – to their Gq and Gi/o protein-coupled receptors (P2Y1R and CXCR4)
stimulates Ca2+ mobilization from internal stores. P2Y1R and/or
CXCR4-mediated intracellular Ca2+ elevations trigger an ensuing cascade of
pathways involving the production and secretion of TNFα and PGE2, TNFR
and EP activation, EP-induced Ca2+ elevations, and ultimately followed by the
release of glutamate from astrocytes. For simplicity TNFα and PGE2 have
been depicted as acting on the same astrocyte from which they are
released; i.e., in an autocrine manner, although they can also act on
neighboring astrocytes to propagate signals in a paracrine way and induce
glutamate release. While astrocytic P2Y1R activation may also induce
Ca2+-dependent release of glutamate without implication of TNFα, TNFα
(from microglial and astrocytic origin), and PGE2 dramatically enhance the
astrocyte glutamate response. The locally elevated Ca2+ due to activation of
P2Y1R, CXCR4, and EPs, working alone or in concert, propagates some
distance into astrocytic compartments including the sheet-like processes
surrounding synapses where it encounters small and diffuse synaptic-like
microvesicles which are triggered to exocytose glutamate into the
extracellular space. Additionally, EP-mediated Ca2+ increases in astrocytes
can also induce the release of ATP, which through autocrine/paracrine
activation of astrocytic P2YRs evokes regenerative intercellular Ca2+ waves.
Definitive proof for Ca2+-dependent astrocyte glutamate release to occur via
exocytosis awaits further evidence. The overall glutamate release from
astrocytes can occur within seconds to minutes of a triggering stimulus to
increase ongoing pre- and postsynaptic mGluR- and/or NMDA
receptor-mediated synaptic transmission, which may be a critical early step
contributing to the initiation of neuronal signaling cascades leading to
hyperexcitability, excitotoxicity, and cell death. Therefore the transduction
pathways depicted in this figure could be potential targets for therapy of
multiple neurological, neuroinflammatory, and neurodegenerative disorders.
astrocytes may be mediated by Ca2+ elevations downstream of
not only Gq (P2Y1R) GPCRs, but also Gi/o (CXCR4) or Gi/Gs
(EP) GPCRs. Additionally, the ligands of these receptors (ATP,
SDF-1α, PGE2) and the ligand for TNFR (TNFα) appear to be
mainly of microglial and astrocytic origin (Asensio and Campbell,
1999; Bajetto et al., 1999; Sanzgiri et al., 1999; Bezzi et al., 2001;
Rostasy et al., 2003; Domercq et al., 2006; Peng et al., 2006; Rossi
and Volterra, 2009; Santello et al., 2011; Pascual et al., 2012) and
not of presynaptic origin; although, a contribution of ATP co-
released with glutamate from neuronal afferents (Khakh, 2001) or
of neuronal SDF-1α (Rostasy et al., 2003) cannot be excluded. The
seconds to minutes timescale for the astrocytic glutamate response
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to occur fits with the timing expected of a metabotropic signaling
pathway and also indicates that microglia can become activated,
and astrocytes reactive, very quickly in response to a triggering
stimulus (Figure 5). The data suggest that inflammation – in
response to infection or injury, rather than synaptically induced
stimulation of astrocytic GPCRs – is essential for triggering glu-
tamate release from astrocytes to subsequently increase ongoing
excitatory synaptic transmission (Figure 5). These emerging find-
ings also need to be taken into consideration in the interpretation
of studies that have used tetanus toxin to block glutamate exocy-
tosis from astrocytes (Bezzi et al., 2001). Transport of cell surface
connexin hemichannels or volume-activated Cl− channels to the
membrane via exosome trafficking may also be impaired by incu-
bation in tetanus toxin (Proux-Gillardeaux et al., 2005), which
could alter efflux of glutamate into the extracellular space by
these alternate pathways (Malarkey and Parpura, 2008). Tetanus
toxin would also presumably affect: (i) the transport of mul-
tidrug resistance protein 4 (MRP4) – a PGE2 export pump – to
the membrane (Reid et al., 2003; Proux-Gillardeaux et al., 2005;
Ronaldson et al., 2008) which could alter PGE2 release; or (ii)
exocytosis of cytokine vesicular carriers which could decrease the
secretion of inflammatory mediators (e.g., TNFα or other uniden-
tified factors; Stow et al., 2009; Duitman et al., 2011). Thus, caution
needs to be exercised in the interpretation of experiments using
blockers of exocytosis or Ca2+ chelators in astrocytes (see discus-
sion above) in combination with neuronal electrophysiological
readouts, which may lead to misinterpretation of how astrocytes
actually control extracellular glutamate levels in a Ca2+-dependent
manner.
Glial inflammatory mediators such as SDF-1α or TNFα are
expressed in the healthy brain, albeit at much lower levels than
during inflammatory reactions and are thought to be implicated
in regulating homeostatic brain functions (Vitkovic et al., 2000;
Bajetto et al., 2001; Beattie et al., 2002; Stellwagen et al., 2005;
Stellwagen and Malenka, 2006; Kaneko et al., 2008; Boulanger,
2009). Furthermore, Santello et al. (2011) reported that knock-
out of TNFα prevented P2Y1R Ca2+-dependent glutamate release
from astrocytes in acute hippocampal slices from otherwise
healthy mice. Therefore, constitutive levels of inflammatory medi-
ators could also regulate to some extent astrocytic glutamate
release in brain tissue from healthy mice. However, it is worth
noting that astrocytic inflammatory mediator-dependent gluta-
mate release has been obtained in cultured astrocytes, mixed
microglia/astrocyte co-cultures or acute hippocampal slices (Bezzi
et al., 1998, 2001; Sanzgiri et al., 1999; Domercq et al., 2006; Cali
et al., 2008; Santello et al., 2011; Pascual et al., 2012). Microglia
and astrocytes, by virtue of culturing conditions become acti-
vated (Cahoy et al., 2008; Zamanian et al., 2012), and their
activity would therefore resemble more closely that which occurs
in the late stages of inflammation. Acute slices, while offering
the advantage of maintaining relationships between cell types
and limiting reactive changes induced by culturing, are never-
theless also compromised to varying degrees. The slicing process
invariably causes cellular and tissue damage including axotomy
of afferent fibers (Coltman and Ide, 1996), accompanied by
immediate release of ATP via cytolysis due to cell membrane
damage, which may only be partially recovered during the sub-
sequent incubation process (Bodin and Burnstock, 2001; Cook
and McCleskey, 2002; Fiala et al., 2003). Central nervous system
tissue can exhibit elevated ATP release for several hours after
trauma (Wang et al., 2004). This form of lesion/trauma-induced
injury is likely to cause activation of microglia (Nimmerjahn
et al., 2005; Haynes et al., 2006; Ohsawa and Kohsaka, 2011)
and astrocytes (Fiala et al., 2003; Neary et al., 2003) within the
first minute of slicing. It is therefore reasonable to suggest that
microglia and astrocytes in acute slices may be releasing higher
levels of inflammatory mediators than they would do otherwise
in vivo. This may make astrocytes more sensitive to stimula-
tion by neurotransmitters or bath application of ATP, SDF-1α,
TNFα, or PGE2. Astrocytic Ca2+-dependent glutamate release in
these conditions may therefore most likely reflect responses of
activated microglia and reactive astrocytes at the early stages of
inflammation rather than physiological roles of presumed rest-
ing glial cells. In any case, differences in levels of TNFα and
other inflammatory mediators between slice preparations could
explain the variability between groups to produce or observe
Ca2+-dependent glutamate release by astrocytes. Carefully con-
trolled future studies in vivo may partially circumvent pathol-
ogy associated with cell culture and acutely isolated brain slices,
and help resolve whether astrocytic GPCR Ca2+-dependent glu-
tamate release is relevant in physiological and/or pathological
situations.
SUMMARY AND PERSPECTIVES
A “calcium-centric” view has pervaded astrocyte research ever
since the discovery of propagating astrocyte intercellular Ca2+
waves in vitro in the early 1990s (e.g., Cornell-Bell et al., 1990).
While astrocyte Ca2+ increases undoubtedly play a role in cer-
tain aspects of astrocyte function, accumulating evidence suggests
that there is more to astrocyte physiology than Ca2+ elevations.
One of the most documented areas of astrocyte research over
the past 20 years has been Gq GPCR Ca2+-dependent gliotrans-
mitter exocytosis to acutely modulate the excitability of adjacent
astrocytes and neurons. However, gliotransmission in healthy tis-
sue has been called into question based on numerous findings.
First, some studies have reported that selective stimulation or
removal of Gq GPCR-dependent astrocyte Ca2+ elevations does
not result in changes in neuronal synaptic transmission and plas-
ticity, suggesting that astrocyte Ca2+ elevations are not sufficient
to trigger the release of gliotransmitters (ATP, d-serine, gluta-
mate). Second, new research suggests that basal or resting astrocyte
Ca2+ levels need to be carefully considered when Ca2+ chela-
tors are infused into the astrocyte syncytium, which will block
not only synaptically induced astrocyte Gq GPCR Ca2+ eleva-
tions, but also resting astrocyte Ca2+ levels. Manipulation of
resting astrocyte Ca2+ may affect neuronal activity via mecha-
nisms including changes in neurotransmitter uptake or ambient
neurotransmitter concentrations. Third, propagating intercellular
Ca2+ waves between astrocytes indicating release of the glio-
transmitter ATP have not been substantiated in intact brain tis-
sue from healthy subjects, arguing against gliotransmitter release
in normal physiology. Last, because the endogenous means by
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which synaptically induced astrocyte Ca2+ elevations occur is
through activation of Gq GPCRs, the kinetics of astrocyte Ca2+
elevations seem too slow to modulate neuronal synaptic activity
occurring on a millisecond timescale (Figure 4). It only seems
possible that astrocytes could modulate neuronal activity in a
Gq GPCR-dependent manner seconds after the initiating neu-
ronal stimulus, supporting the concept that astrocytes act as
“re-suppliers” to support synaptic transmission through recov-
ery of neuronal metabolism or re-establishment of extracellu-
lar transmitter homeostasis. The fact that neuronally evoked Gq
GPCR Ca2+ elevations in astrocytes are not sufficient to trigger
gliotransmitter release to acutely modulate neurotransmission in
the healthy brain, but instead would have a role in maintaining
the homeostatic levels of ambient transmitters or ions, has pro-
found implications in our understanding of synaptic transmission.
Indeed, the concept of astrocytes being the third functional ele-
ment of the synapse, in addition to the pre- and postsynaptic
compartments, by releasing gliotransmitters to acutely (millisec-
ond timescale) influence synaptic transmission affects the inter-
pretation of a broad range of findings in neurophysiology. Thus,
we propose that synaptically induced Gq GPCR Ca2+-dependent
release of gliotransmitters (i.e., gliotransmission) be rebranded as
gliomodulation.
Emerging research is suggesting that Ca2+-dependent release
of gliotransmitters (glutamate and ATP) is also dependent on
activated microglia, reactive astrocytes, and inflammatory mol-
ecules (Figure 5). These molecules include ATP, SDF-1α, TNFα,
and PGE2, mediators that are rapidly upregulated and secreted
by activated microglia and reactive astrocytes. This new infor-
mation is exciting for the following reasons: First, it provides a
possible explanation for the disparate findings among research
groups regarding the Ca2+-dependence of gliotransmitter release
from astrocytes (Agulhon et al., 2008; Hamilton and Attwell,
2010). Second, because it appears that activated microglia and
increased release of inflammatory mediators and glutamate can
occur rapidly, within seconds to minutes, glutamate release by
reactive astrocytes may be a key early event in the progression of
changes leading to neuronal hyperexcitability and excitotoxicity
in neurological disorders and neuroinflammatory and neurode-
generative diseases. The observation that Ca2+-dependent release
of glutamate by astrocytes depends on glial mediators, as well as
the second-to-minute time course of this response, argues that
gliomodulation but not gliotransmission is involved. Definitive
proof for Ca2+-dependent astrocyte glutamate release to occur
via exocytosis awaits further evidence, and mechanisms other
than exocytosis might also be at work including release through
volume-regulated anion channels, pore-forming P2X7 channels,
connexin hemichannels, or reversal of glutamate uptake (Haskew-
Layton et al., 2008; Malarkey and Parpura, 2008;Zhang et al.,
2008, 2011; Li et al., 2012). It will be important in future studies
assessing the impact of astrocyte transmitter release in patho-
logical conditions to dissociate between these alternative release
pathways. The IP3R2 KO mice will be particularly useful for
dissociating astrocyte Ca2+ specifically from other astrocyte trans-
mitter release mechanisms. Future experiments that can measure
and manipulate secretion and levels of inflammatory mediators
in vivo may also provide more compelling information regard-
ing the conditions required for inflammatory mediator/Ca2+-
dependent release of gliotransmitters by astrocytes. Overall, these
findings provide promising new glial targets for therapeutical
intervention to treat a wide range of central nervous system
pathologies.
ACKNOWLEDGMENTS
This work was supported by a grant (Chair of Excellence) from the
Paris School of Neuroscience (Ecole des Neurosciences de Paris) to
Cendra Agulhon, and an Epilepsy Foundation grant and a Hellman
Foundation fellowship to Todd A. Fiacco.
REFERENCES
Aguado, F., Espinosa-Parrilla, J. F.,
Carmona, M. A., and Soriano, E.
(2002). Neuronal activity regulates
correlated network properties of
spontaneous calcium transients in
astrocytes in situ. J. Neurosci. 22,
9430–9444.
Agulhon, C., Fiacco, T. A., and
McCarthy, K. D. (2010). Hippocam-
pal short- and long-term plastic-
ity are not modulated by astro-
cyte Ca2+ signaling. Science 327,
1250–1254.
Agulhon, C., Petravicz, J., McMullen,
A. B., Sweger, E. J., Minton, S. K.,
Taves, S. R., Casper, K. B., Fiacco,
T. A., and McCarthy, K. D. (2008).
What is the role of astrocyte cal-
cium in neurophysiology? Neuron
59, 932–946.
Alvarez, S., Blanco, A., Fresno, M., and
Munoz-Fernandez, M. A. (2010).
Nuclear factor-kappaB activa-
tion regulates cyclooxygenase-2
induction in human astrocytes
in response to CXCL12: role in
neuronal toxicity. J. Neurochem.
113, 772–783.
Araque, A., Sanzgiri, R. P., Parpura, V.,
and Haydon, P. G. (1998). Calcium
elevation in astrocytes causes an
NMDA receptor-dependent increase
in the frequency of miniature synap-
tic currents in cultured hippocampal
neurons. J. Neurosci. 18, 6822–6829.
Araque, A., Sanzgiri, R. P., Parpura, V.,
and Haydon, P. G. (1999). Astrocyte-
induced modulation of synaptic
transmission. Can. J. Physiol. Phar-
macol. 77, 699–706.
Arcuino, G., Lin, J. H., Takano, T., Liu,
C., Jiang, L., Gao, Q., Kang, J., and
Nedergaard, M. (2002). Intercellu-
lar calcium signaling mediated by
point-source burst release of ATP.
Proc. Natl. Acad. Sci. U.S.A. 99,
9840–9845.
Aronica, E., Gorter, J. A., Jansen, G.
H., van Veelen, C. W., van Rijen,
P. C., Ramkema, M., and Troost,
D. (2003). Expression and cell dis-
tribution of group I and group
II metabotropic glutamate receptor
subtypes in taylor-type focal cortical
dysplasia. Epilepsia 44, 785–795.
Asensio, V. C., and Campbell, I. L.
(1999). Chemokines in the CNS:
plurifunctional mediators in diverse
states. Trends Neurosci. 22, 504–512.
Bajetto, A., Bonavia, R., Barbero, S.,
Florio, T., and Schettini, G. (2001).
Chemokines and their receptors in
the central nervous system. Front.
Neuroendocrinol. 22, 147–184.
Bajetto, A., Bonavia, R., Barbero, S.,
Piccioli, P., Costa, A., Florio, T.,
and Schettini, G. (1999). Glial
and neuronal cells express func-
tional chemokine receptor CXCR4
and its natural ligand stromal cell-
derived factor 1. J. Neurochem. 73,
2348–2357.
Basarsky, T. A., Duffy, S. N., Andrew,
R. D., and MacVicar, B. A. (1998).
Imaging spreading depression and
associated intracellular calcium
waves in brain slices. J. Neurosci. 18,
7189–7199.
Beattie, E. C., Stellwagen, D., Mor-
ishita, W., Bresnahan, J. C., Ha,
B. K., Von Zastrow, M., Beat-
tie, M. S., and Malenka, R. C.
(2002). Control of synaptic strength
by glial TNFalpha. Science 295,
2282–2285.
Benneyworth, M. A., Li, Y., Basu, A.
C., Bolshakov, V. Y., and Coyle,
J. T. (2012). Cell selective condi-
tional null mutations of serine race-
mase demonstrate a predominate
localization in cortical glutamater-
gic neurons. Cell. Mol. Neurobiol. 32,
613–624.
Bezzi, P., Carmignoto, G., Pasti, L.,
Vesce, S., Rossi, D., Rizzini, B. L.,
Pozzan, T., and Volterra, A. (1998).
Prostaglandins stimulate calcium-
dependent glutamate release in
astrocytes. Nature 391, 281–285.
Frontiers in Pharmacology | Neuropharmacology July 2012 | Volume 3 | Article 139 | 12
Agulhon et al. Gliotransmission in normal vs. reactive astrocytes
Bezzi, P., Domercq, M., Brambilla, L.,
Galli, R., Schols, D., De Clercq,
E., Vescovi, A., Bagetta, G., Kol-
lias, G., Meldolesi, J., and Volterra,
A. (2001). CXCR4-activated astro-
cyte glutamate release via TNFal-
pha: amplification by microglia trig-
gers neurotoxicity. Nat. Neurosci. 4,
702–710.
Binder, D. K., and Steinhauser, C.
(2006). Functional changes in
astroglial cells in epilepsy. Glia 54,
358–368.
Bloodgood, B. L., and Sabatini, B. L.
(2007). Nonlinear regulation of uni-
tary synaptic signals by CaV(2.3)
voltage-sensitive calcium channels
located in dendritic spines. Neuron
53, 249–260.
Bodin, P., and Burnstock, G. (2001).
Purinergic signalling: ATP release.
Neurochem. Res. 26, 959–969.
Boulanger, L. M. (2009). Immune
proteins in brain development
and synaptic plasticity. Neuron 64,
93–109.
Bowser, D. N., and Khakh, B. S. (2007).
Vesicular ATP is the predominant
cause of intercellular calcium waves
in astrocytes. J. Gen. Physiol. 129,
485–491.
Brambilla, R., Persaud, T., Hu, X.,
Karmally, S., Shestopalov, V. I.,
Dvoriantchikova, G., Ivanov, D.,
Nathanson, L., Barnum, S. R.,
and Bethea, J. R. (2009). Trans-
genic inhibition of astroglial NF-
kappa B improves functional out-
come in experimental autoim-
mune encephalomyelitis by sup-
pressing chronic central nervous sys-
tem inflammation. J. Immunol. 182,
2628–2640.
Busch, E., Gyngell, M. L., Eis, M.,
Hoehn-Berlage, M., and Hossmann,
K. A. (1996). Potassium-induced
cortical spreading depressions
during focal cerebral ischemia in
rats: contribution to lesion growth
assessed by diffusion-weighted
NMR and biochemical imaging.
J. Cereb. Blood Flow Metab. 16,
1090–1099.
Cahoy, J. D., Emery, B., Kaushal, A.,
Foo, L. C., Zamanian, J. L., Christo-
pherson, K. S., Xing, Y., Lubischer,
J. L., Krieg, P. A., Krupenko, S. A.,
Thompson, W. J., and Barres, B.
A. (2008). A transcriptome data-
base for astrocytes, neurons, and
oligodendrocytes: a new resource
for understanding brain develop-
ment and function. J. Neurosci. 28,
264–278.
Cali, C., Marchaland, J., Regazzi, R.,
and Bezzi, P. (2008). SDF 1-
alpha (CXCL12) triggers glutamate
exocytosis from astrocytes on a
millisecond time scale: imaging
analysis at the single-vesicle level
with TIRF microscopy. J. Neuroim-
munol. 198, 82–91.
Carmignoto, G., Pasti, L., and Poz-
zan, T. (1998). On the role of
voltage-dependent calcium chan-
nels in calcium signaling of astro-
cytes in situ. J. Neurosci. 18,
4637–4645.
Cavelier,P., and Attwell,D. (2005). Tonic
release of glutamate by a DIDS-
sensitive mechanism in rat hip-
pocampal slices. J. Physiol. (Lond.)
564, 397–410.
Cavelier, P., Hamann, M., Rossi, D.,
Mobbs, P., and Attwell, D. (2005).
Tonic excitation and inhibition
of neurons: ambient transmitter
sources and computational conse-
quences. Prog. Biophys. Mol. Biol. 87,
3–16.
Chuquet, J., Hollender, L., and
Nimchinsky, E. A. (2007). High-
resolution in vivo imaging of the
neurovascular unit during spread-
ing depression. J. Neurosci. 27,
4036–4044.
Colangelo, A. M., Cirillo, G., Lavit-
rano, M. L., Alberghina, L., and
Papa, M. (2012). Targeting reactive
astrogliosis by novel biotechnolog-
ical strategies. Biotechnol. Adv. 30,
261–271.
Coltman, B. W., and Ide, C. F. (1996).
Temporal characterization of
microglia, IL-1 beta-like immunore-
activity and astrocytes in the dentate
gyrus of hippocampal organotypic
slice cultures. Int. J. Dev. Neurosci.
14, 707–719.
Cook, S. P., and McCleskey, E. W.
(2002). Cell damage excites nocicep-
tors through release of cytosolic ATP.
Pain 95, 41–47.
Cornell-Bell, A. H., Finkbeiner, S. M.,
Cooper, M. S., and Smith, S. J.
(1990). Glutamate induces calcium
waves in cultured astrocytes: long-
range glial signaling. Science 247,
470–473.
Cotrina, M. L., Lin, J. H., Lopez-
Garcia, J. C., Naus, C. C., and Ned-
ergaard, M. (2000). ATP-mediated
glia signaling. J. Neurosci. 20,
2835–2844.
Di Castro, M. A., Chuquet, J., Liaudet,
N., Bhaukaurally, K., Santello, M.,
Bouvier, D., Tiret, P., and Volterra,
A. (2011). Local Ca2+ detection
and modulation of synaptic release
by astrocytes. Nat. Neurosci. 14,
1276–1284.
Di Cesare, A., Del Piccolo, P., Zac-
chetti, D., and Grohovaz, F. (2006).
EP2 receptor stimulation promotes
calcium responses in astrocytes via
activation of the adenylyl cyclase
pathway. Cell. Mol. Life Sci. 63,
2546–2553.
Dombeck, D. A., Khabbaz, A. N., Coll-
man, F., Adelman, T. L., and Tank,
D. W. (2007). Imaging large-scale
neural activity with cellular resolu-
tion in awake, mobile mice. Neuron
56, 43–57.
Domercq, M., Brambilla, L., Pilati, E.,
Marchaland, J., Volterra, A., and
Bezzi, P. (2006). P2Y1 receptor-
evoked glutamate exocytosis from
astrocytes: control by tumor necro-
sis factor-alpha and prostaglandins.
J. Biol. Chem. 281, 30684–30696.
Dreier, J. P., Woitzik, J., Fabricius,
M., Bhatia, R., Major, S., Drenck-
hahn, C., Lehmann, T. N., Sar-
rafzadeh, A., Willumsen, L., Hart-
ings, J. A., Sakowitz, O. W., See-
mann, J. H., Thieme, A., Lau-
ritzen, M., and Strong, A. J.
(2006). Delayed ischaemic neuro-
logical deficits after subarachnoid
haemorrhage are associated with
clusters of spreading depolariza-
tions. Brain 129, 3224–3237.
Duitman, E. H., Orinska, Z., and
Bulfone-Paus, S. (2011). Mecha-
nisms of cytokine secretion: a port-
folio of distinct pathways allows flex-
ibility in cytokine activity. Eur. J. Cell
Biol. 90, 476–483.
Fabricius, M., Fuhr, S., Bhatia, R.,
Boutelle, M., Hashemi, P., Strong, A.
J., and Lauritzen, M. (2006). Corti-
cal spreading depression and peri-
infarct depolarization in acutely
injured human cerebral cortex.
Brain 129, 778–790.
Farina, C., Aloisi, F., and Meinl, E.
(2007). Astrocytes are active players
in cerebral innate immunity. Trends
Immunol. 28, 138–145.
Farso, M. C., O’Shea, R. D., and Beart, P.
M. (2009). Evidence group I mGluR
drugs modulate the activation pro-
file of lipopolysaccharide-exposed
microglia in culture. Neurochem.
Res. 34, 1721–1728.
Fedirko, N., Avshalumov, M., Rice,
M. E., and Chesler, M. (2007).
Regulation of postsynaptic Ca2+
influx in hippocampal CA1 pyra-
midal neurons via extracellular car-
bonic anhydrase. J. Neurosci. 27,
1167–1175.
Fiacco, T. A., Agulhon, C., Taves, S.
R., Petravicz, J., Casper, K. B.,
Dong, X., Chen, J., and McCarthy,
K. D. (2007). Selective stimula-
tion of astrocyte calcium in situ
does not affect neuronal excita-
tory synaptic activity. Neuron 54,
611–626.
Fiacco, T. A., and McCarthy, K. D.
(2004). Intracellular astrocyte cal-
cium waves in situ increase the
frequency of spontaneous AMPA
receptor currents in CA1 pyramidal
neurons. J. Neurosci. 24, 722–732.
Fiacco, T. A., and McCarthy, K. D.
(2006). Astrocyte calcium eleva-
tions: properties, propagation, and
effects on brain signaling. Glia 54,
676–690.
Fiala, J. C., Kirov, S. A., Feinberg, M.
D., Petrak, L. J., George, P., God-
dard, C. A., and Harris, K. M.
(2003). Timing of neuronal and glial
ultrastructure disruption during
brain slice preparation and recov-
ery in vitro. J. Comp. Neurol. 465,
90–103.
Goldshmit, Y., McLenachan, S., and
Turnley, A. (2006). Roles of Eph
receptors and ephrins in the normal
and damaged adult CNS. Brain Res.
Rev. 52, 327–345.
Hadjikhani, N., Sanchez Del Rio, M.,
Wu, O., Schwartz, D., Bakker, D.,
Fischl, B., Kwong, K. K., Cutrer, F.
M., Rosen, B. R., Tootell, R. B.,
Sorensen, A. G., and Moskowitz, M.
A. (2001). Mechanisms of migraine
aura revealed by functional MRI
in human visual cortex. Proc. Natl.
Acad. Sci. U.S.A. 98, 4687–4692.
Halassa, M. M., Fellin, T., and Haydon,
P. G. (2007). The tripartite synapse:
roles for gliotransmission in health
and disease. Trends Mol. Med. 13,
54–63.
Hamby, M. E., and Sofroniew, M. V.
(2010). Reactive astrocytes as ther-
apeutic targets for CNS disorders.
Neurotherapeutics 7, 494–506.
Hamilton, N., Vayro, S., Wigley, R., and
Butt, A. M. (2010). Axons and astro-
cytes release ATP and glutamate to
evoke calcium signals in NG2-glia.
Glia 58, 66–79.
Hamilton, N. B., and Attwell, D. (2010).
Do astrocytes really exocytose neu-
rotransmitters? Nat. Rev. Neurosci.
11, 227–238.
Han, Y., He, T., Huang, D. R., Pardo,
C. A., and Ransohoff, R. M.
(2001). TNF-alpha mediates SDF-
1 alpha-induced NF-kappa B acti-
vation and cytotoxic effects in pri-
mary astrocytes. J. Clin. Invest. 108,
425–435.
Haskew-Layton, R. E., Rudkouskaya,
A., Jin, Y., Feustel, P. J., Kimelberg,
H. K., and Mongin, A. A. (2008).
Two distinct modes of hypoosmotic
medium-induced release of excita-
tory amino acids and taurine in the
rat brain in vivo. PLoS ONE 3, e3543.
doi:10.1371/journal.pone.0003543
Haydon, P. G. (2001). GLIA: listening
and talking to the synapse. Nat. Rev.
Neurosci. 2, 185–193.
Haynes, S. E., Hollopeter, G., Yang, G.,
Kurpius, D., Dailey, M. E., Gan, W.
www.frontiersin.org July 2012 | Volume 3 | Article 139 | 13
Agulhon et al. Gliotransmission in normal vs. reactive astrocytes
B., and Julius, D. (2006). The P2Y12
receptor regulates microglial acti-
vation by extracellular nucleotides.
Nat. Neurosci. 9, 1512–1519.
Henneberger, C., Papouin, T., Oliet,
S. H., and Rusakov, D. A. (2010).
Long-term potentiation depends on
release of D-serine from astrocytes.
Nature 463, 232–236.
Hirase, H., Qian, L., Bartho, P.,
and Buzsaki, G. (2004). Calcium
dynamics of cortical astrocytic net-
works in vivo. PLoS Biol. 2, e96.
doi:10.1371/journal.pbio.0020096
Hsiao, H. Y., Mak, O. T., Yang, C.
S., Liu, Y. P., Fang, K. M., and
Tzeng, S. F. (2007). TNF-alpha/IFN-
gamma-induced iNOS expression
increased by prostaglandin E2 in
rat primary astrocytes via EP2-
evoked cAMP/PKA and intracel-
lular calcium signaling. Glia 55,
214–223.
Ikeda-Matsuo, Y., Ikegaya, Y., Mat-
suki, N., Uematsu, S., Akira, S.,
and Sasaki, Y. (2005). Microglia-
specific expression of microso-
mal prostaglandin E2 synthase-1
contributes to lipopolysaccharide-
induced prostaglandin E2 produc-
tion. J. Neurochem. 94, 1546–1558.
Jabaudon, D., Shimamoto, K., Yasuda-
Kamatani, Y., Scanziani, M., Gah-
wiler, B. H., and Gerber, U. (1999).
Inhibition of uptake unmasks rapid
extracellular turnover of glutamate
of nonvesicular origin. Proc. Natl.
Acad. Sci. U.S.A. 96, 8733–8738.
Jabs, R., Pivneva, T., Huttmann, K.,
Wyczynski, A., Nolte, C., Ketten-
mann, H., and Steinhauser, C.
(2005). Synaptic transmission onto
hippocampal glial cells with hGFAP
promoter activity. J. Cell. Sci. 118,
3791–3803.
James, M. F., Smith, J. M., Boniface, S.
J., Huang, C. L., and Leslie, R. A.
(2001). Cortical spreading depres-
sion and migraine: new insights
from imaging? Trends Neurosci. 24,
266–271.
Johnson, J. W., and Ascher, P. (1987).
Glycine potentiates the NMDA
response in cultured mouse brain
neurons. Nature 325, 529–531.
Kaneko, M., Stellwagen, D., Malenka,
R. C., and Stryker, M. P. (2008).
Tumor necrosis factor-alpha medi-
ates one component of competitive,
experience-dependent plasticity in
developing visual cortex. Neuron 58,
673–680.
Kartvelishvily, E., Shleper, M., Balan, L.,
Dumin, E., and Wolosker, H. (2006).
Neuron-derived D-serine release
provides a novel means to activate
N-methyl-D-aspartate receptors. J.
Biol. Chem. 281, 14151–14162.
Kaul, M., and Lipton, S. A. (1999).
Chemokines and activated
macrophages in HIV gp120-induced
neuronal apoptosis. Proc. Natl. Acad.
Sci. U.S.A. 96, 8212–8216.
Khakh, B. S. (2001). Molecular phys-
iology of P2X receptors and ATP
signalling at synapses. Nat. Rev. Neu-
rosci. 2, 165–174.
Kimelberg, H. K. (2007). Supportive or
information-processing functions of
the mature protoplasmic astrocyte
in the mammalian CNS? A criti-
cal appraisal. Neuron Glia Biol. 3,
181–189.
Kirchhoff, F. (2010). Neuroscience.
Questionable calcium. Science 327,
1212–1213.
Kuchibhotla, K. V., Lattarulo, C. R.,
Hyman, B. T., and Bacskai, B. J.
(2009). Synchronous hyperactivity
and intercellular calcium waves in
astrocytes in Alzheimer mice. Science
323, 1211–1215.
Kunkler, P. E., and Kraig, R. P. (1998).
Calcium waves precede electro-
physiological changes of spreading
depression in hippocampal organ
cultures. J. Neurosci. 18, 3416–3425.
Lau, A., and Tymianski, M. (2010). Glu-
tamate receptors, neurotoxicity and
neurodegeneration. Pflugers Arch.
460, 525–542.
Le Meur, K., Galante, M., Angulo,
M. C., and Audinat, E. (2007).
Tonic activation of NMDA recep-
tors by ambient glutamate of non-
synaptic origin in the rat hip-
pocampus. J. Physiol. (Lond.) 580,
373–383.
Li, D., Herault, K., Isacoff, E. Y.,
Oheim, M., and Ropert, N. (2012).
Optogenetic activation of LiGluR-
expressing astrocytes evokes anion
channel-mediated glutamate release.
J. Physiol. (Lond.) 590, 855–873.
Lin, S. C., and Bergles, D. E.
(2002). Physiological characteristics
of NG2-expressing glial cells. J. Neu-
rocytol. 31, 537–549.
Lin, S. C., and Bergles, D. E. (2004).
Synaptic signaling between neurons
and glia. Glia 47, 290–298.
Lin, S. C., Huck, J. H., Roberts, J. D.,
Macklin, W. B., Somogyi, P., and
Bergles, D. E. (2005). Climbing fiber
innervation of NG2-expressing glia
in the mammalian cerebellum. Neu-
ron 46, 773–785.
Liu, W., Tang, Y., and Feng, J. (2011).
Cross talk between activation of
microglia and astrocytes in patho-
logical conditions in the cen-
tral nervous system. Life Sci. 89,
141–146.
Lucas, S. M., Rothwell, N. J., and Gib-
son, R. M. (2006). The role of
inflammation in CNS injury and
disease. Br. J. Pharmacol. 147(Suppl.
1), S232–S240.
Machado, A., Herrera, A. J., Venero,
J. L., Santiago, M., De Pablos, R.
M., Villaran, R. F., Espinosa-Oliva,
A. M., Arguelles, S., Sarmiento, M.,
Delgado-Cortes, M. J., Maurino,
R., and Cano, J. (2011). Peripheral
inflammation increases the dam-
age in animal models of nigrostri-
atal dopaminergic neurodegenera-
tion: possible implication in Parkin-
son’s disease incidence. Parkinsons
Dis. 2011, 393769.
Malarkey, E. B., and Parpura, V. (2008).
Mechanisms of glutamate release
from astrocytes. Neurochem. Int. 52,
142–154.
Matthias, K., Kirchhoff, F., Seifert, G.,
Huttmann, K., Matyash, M., Ket-
tenmann, H., and Steinhauser, C.
(2003). Segregated expression of
AMPA-type glutamate receptors and
glutamate transporters defines dis-
tinct astrocyte populations in the
mouse hippocampus. J. Neurosci. 23,
1750–1758.
Miller, R. F. (2004). D-Serine as a glial
modulator of nerve cells. Glia 47,
275–283.
Miya, K., Inoue, R., Takata, Y., Abe, M.,
Natsume, R., Sakimura, K., Hon-
gou, K., Miyawaki, T., and Mori,
H. (2008). Serine racemase is pre-
dominantly localized in neurons in
mouse brain. J. Comp. Neurol. 510,
641–654.
Mothet, J. P., Parent, A. T., Wolosker, H.,
Brady, R. O. Jr., Linden, D. J., Ferris,
C. D., Rogawski, M. A., and Snyder,
S. H. (2000). D-serine is an endoge-
nous ligand for the glycine site of
the N-methyl-D-aspartate receptor.
Proc. Natl. Acad. Sci. U.S.A. 97,
4926–4931.
Mulligan, S. J., and MacVicar, B. A.
(2004). Calcium transients in astro-
cyte endfeet cause cerebrovascular
constrictions. Nature 431, 195–199.
Navarrete, M., Perea, G., Fernandez
de Sevilla, D., Gomez-Gonzalo, M.,
Nunez,A., Martin, E. D., and Araque,
A. (2012). Astrocytes mediate in vivo
cholinergic-induced synaptic plas-
ticity. PLoS Biol. 10, e1001259.
doi:10.1371/journal.pbio.1001259
Neary, J. T., Kang, Y., Willoughby,
K. A., and Ellis, E. F. (2003).
Activation of extracellular signal-
regulated kinase by stretch-induced
injury in astrocytes involves extra-
cellular ATP and P2 puriner-
gic receptors. J. Neurosci. 23,
2348–2356.
Nedergaard, M. (1996). Spreading
depression as a contributor to
ischemic brain damage. Adv. Neurol.
71, 75–83; discussion 83–74.
Nett, W. J., Oloff, S. H., and McCarthy,
K. D. (2002). Hippocampal astro-
cytes in situ exhibit calcium oscil-
lations that occur independent of
neuronal activity. J. Neurophysiol. 87,
528–537.
Newman, E. A. (2001). Propagation of
intercellular calcium waves in reti-
nal astrocytes and Muller cells. J.
Neurosci. 21, 2215–2223.
Nimmerjahn, A., Kirchhoff, F., and
Helmchen, F. (2005). Resting
microglial cells are highly dynamic
surveillants of brain parenchyma
in vivo. Science 308, 1314–1318.
Nishiyama, A., Yang, Z., and Butt, A.
(2005). Astrocytes and NG2-glia:
what’s in a name? J. Anat. 207,
687–693.
Ohsawa, K., and Kohsaka, S. (2011).
Dynamic motility of microglia:
purinergic modulation of microglial
movement in the normal and patho-
logical brain. Glia 59, 1793–1799.
Ortinski, P. I., Dong, J., Mungenast, A.,
Yue, C., Takano, H., Watson, D. J.,
Haydon, P. G., and Coulter, D. A.
(2010). Selective induction of astro-
cytic gliosis generates deficits in neu-
ronal inhibition. Nat. Neurosci. 13,
584–591.
Panatier, A., Vallee, J., Haber, M., Murai,
K. K., Lacaille, J. C., and Robitaille,
R. (2011). Astrocytes are endoge-
nous regulators of basal transmis-
sion at central synapses. Cell 146,
785–798.
Pardo, A. C., Wong, V., Benson, L.
M., Dykes, M., Tanaka, K., Roth-
stein, J. D., and Maragakis, N. J.
(2006). Loss of the astrocyte glu-
tamate transporter GLT1 modifies
disease in SOD1(G93A) mice. Exp.
Neurol. 201, 120–130.
Parpura, V., Basarsky, T. A., Liu, F., Jef-
tinija, K., Jeftinija, S., and Haydon,
P. G. (1994). Glutamate-mediated
astrocyte-neuron signalling. Nature
369, 744–747.
Parpura, V., and Haydon, P. G.
(2000). Physiological astrocytic cal-
cium levels stimulate glutamate
release to modulate adjacent neu-
rons. Proc. Natl. Acad. Sci. U.S.A. 97,
8629–8634.
Pascual, O., Ben Achour, S., Ros-
taing, P., Triller, A., and Bessis, A.
(2012). Microglia activation triggers
astrocyte-mediated modulation of
excitatory neurotransmission. Proc.
Natl. Acad. Sci. U.S.A. 109, E197–
E205.
Pekny, M., and Nilsson, M. (2005).
Astrocyte activation and reactive
gliosis. Glia 50, 427–434.
Peng, H., Erdmann, N., Whitney, N.,
Dou, H., Gorantla, S., Gendelman,
H. E., Ghorpade, A., and Zheng,
Frontiers in Pharmacology | Neuropharmacology July 2012 | Volume 3 | Article 139 | 14
Agulhon et al. Gliotransmission in normal vs. reactive astrocytes
J. (2006). HIV-1-infected and/or
immune activated macrophages reg-
ulate astrocyte SDF-1 production
through IL-1beta. Glia 54, 619–629.
Perea, G., and Araque, A. (2005). Prop-
erties of synaptically evoked astro-
cyte calcium signal reveal synap-
tic information processing by astro-
cytes. J. Neurosci. 25, 2192–2203.
Perea, G., Navarrete, M., and Araque,
A. (2009). Tripartite synapses: astro-
cytes process and control synap-
tic information. Trends Neurosci. 32,
421–431.
Peters, A., Palay, S. L., and Webster, H.
deF. (1991). The Fine Structure of the
Nervous System: Neurons and Their
Supporting Cells, 3rd Edn. New York:
Oxford University Press, 282.
Peters, O., Schipke, C. G., Hashimoto,Y.,
and Kettenmann, H. (2003). Differ-
ent mechanisms promote astrocyte
Ca2+ waves and spreading depres-
sion in the mouse neocortex. J. Neu-
rosci. 23, 9888–9896.
Petravicz, J., Fiacco, T. A., and McCarthy,
K. D. (2008). Loss of IP3 receptor-
dependent Ca2+ increases in hip-
pocampal astrocytes does not affect
baseline CA1 pyramidal neuron
synaptic activity. J. Neurosci. 28,
4967–4973.
Piet, R., and Jahr, C. E. (2007). Glu-
tamatergic and purinergic receptor-
mediated calcium transients in
Bergmann glial cells. J. Neurosci. 27,
4027–4035.
Pocock, J. M., and Kettenmann, H.
(2007). Neurotransmitter receptors
on microglia. Trends Neurosci. 30,
527–535.
Porter, J. T., and McCarthy, K. D. (1996).
Hippocampal astrocytes in situ
respond to glutamate released from
synaptic terminals. J. Neurosci. 16,
5073–5081.
Porter, J. T., and McCarthy, K. D. (1997).
Astrocytic neurotransmitter recep-
tors in situ and in vivo. Prog. Neu-
robiol. 51, 439–455.
Proux-Gillardeaux, V., Rudge, R.,
and Galli, T. (2005). The tetanus
neurotoxin-sensitive and insensitive
routes to and from the plasma
membrane: fast and slow pathways?
Traffic 6, 366–373.
Qin, L., Li, G., Qian, X., Liu, Y., Wu, X.,
Liu, B., Hong, J. S., and Block, M. L.
(2005). Interactive role of the toll-
like receptor 4 and reactive oxygen
species in LPS-induced microglia
activation. Glia 52, 78–84.
Reid, G., Wielinga, P., Zelcer, N., van
der Heijden, I., Kuil, A., de Haas,
M., Wijnholds, J., and Borst, P.
(2003). The human multidrug resis-
tance protein MRP4 functions as a
prostaglandin efflux transporter and
is inhibited by nonsteroidal antiin-
flammatory drugs. Proc. Natl. Acad.
Sci. U.S.A. 100, 9244–9249.
Rivest, S. (2003). Molecular insights on
the cerebral innate immune system.
Brain Behav. Immun. 17, 13–19.
Ronaldson, P. T., Persidsky, Y., and Ben-
dayan, R. (2008). Regulation of ABC
membrane transporters in glial cells:
relevance to the pharmacotherapy
of brain HIV-1 infection. Glia 56,
1711–1735.
Rosenberg, D., Kartvelishvily, E.,
Shleper, M., Klinker, C. M., Bowser,
M. T., and Wolosker, H. (2010).
Neuronal release of D-serine:
a physiological pathway con-
trolling extracellular D-serine
concentration. FASEB J. 24,
2951–2961.
Rossi, D., and Volterra, A. (2009). Astro-
cytic dysfunction: insights on the
role in neurodegeneration. Brain
Res. Bull. 80, 224–232.
Rostasy, K., Egles, C., Chauhan, A.,
Kneissl, M., Bahrani, P., Yiannout-
sos, C., Hunter, D. D., Nath, A.,
Hedreen, J. C., and Navia, B. A.
(2003). SDF-1alpha is expressed in
astrocytes and neurons in the AIDS
dementia complex: an in vivo and
in vitro study. J. Neuropathol. Exp.
Neurol. 62, 617–626.
Rusakov, D. A., Zheng, K., and Hen-
neberger, C. (2011). Astrocytes as
regulators of synaptic function: a
quest for the Ca2+master key. Neu-
roscientist 17, 513–523.
Santello, M., Bezzi, P., and Volterra,
A. (2011). TNFalpha controls glu-
tamatergic gliotransmission in the
hippocampal dentate gyrus. Neuron
69, 988–1001.
Santello, M., and Volterra, A. (2009).
Synaptic modulation by astro-
cytes via Ca2+-dependent glu-
tamate release. Neuroscience 158,
253–259.
Sanzgiri, R. P., Araque, A., and Hay-
don, P. G. (1999). Prostaglandin
E(2) stimulates glutamate receptor-
dependent astrocyte neuromodula-
tion in cultured hippocampal cells.
J. Neurobiol. 41, 221–229.
Scemes, E., and Giaume, C. (2006).
Astrocyte calcium waves: what they
are and what they do. Glia 54,
716–725.
Schipke, C. G., Boucsein, C., Ohlemeyer,
C., Kirchhoff, F., and Kettenmann,
H. (2002). Astrocyte Ca2+ waves
trigger responses in microglial cells
in brain slices. FASEB J. 16, 255–257.
Schummers, J., Yu, H., and Sur, M.
(2008). Tuned responses of astro-
cytes and their influence on hemo-
dynamic signals in the visual cortex.
Science 320, 1638–1643.
Shaw, P. J. (1993). Excitatory amino
acid receptors, excitotoxicity, and the
human nervous system. Curr. Opin.
Neurol. Neurosurg. 6, 414–422.
Shelton, M. K., and McCarthy, K.
D. (2000). Hippocampal astrocytes
exhibit Ca2+-elevating muscarinic
cholinergic and histaminergic recep-
tors in situ. J. Neurochem. 74,
555–563.
Shigetomi, E., Tong, X., Kwan, K.
Y., Corey, D. P., and Khakh, B.
S. (2012). TRPA1 channels regu-
late astrocyte resting calcium and
inhibitory synapse efficacy through
GAT-3. Nat. Neurosci. 15, 70–80.
Simard, M., Arcuino, G., Takano, T.,
Liu, Q. S., and Nedergaard, M.
(2003). Signaling at the gliovas-
cular interface. J. Neurosci. 23,
9254–9262.
Smith, K. (2010). Neuroscience: settling
the great glia debate. Nature 468,
160–162.
Sofroniew, M. V. (2009). Molecular dis-
section of reactive astrogliosis and
glial scar formation. Trends Neurosci.
32, 638–647.
Steele, M. L., and Robinson, S. R.
(2012). Reactive astrocytes give
neurons less support: implications
for Alzheimer’s disease. Neurobiol.
Aging 33, 423 e421–e413.
Stellwagen, D., Beattie, E. C., Seo, J. Y.,
and Malenka, R. C. (2005). Differen-
tial regulation of AMPA receptor and
GABA receptor trafficking by tumor
necrosis factor-alpha. J. Neurosci. 25,
3219–3228.
Stellwagen, D., and Malenka, R. C.
(2006). Synaptic scaling mediated
by glial TNF-alpha. Nature 440,
1054–1059.
Stow, J. L., Low, P. C., Offenhauser,
C., and Sangermani, D. (2009).
Cytokine secretion in macrophages
and other cells: pathways and medi-
ators. Immunobiology 214, 601–612.
Strong, A. J., Fabricius, M., Boutelle,
M. G., Hibbins, S. J., Hopwood,
S. E., Jones, R., Parkin, M. C.,
and Lauritzen, M. (2002). Spread-
ing and synchronous depressions
of cortical activity in acutely
injured human brain. Stroke 33,
2738–2743.
Takata, N., Mishima, T., Hisatsune, C.,
Nagai, T., Ebisui, E., Mikoshiba,
K., and Hirase, H. (2011). Astro-
cyte calcium signaling transforms
cholinergic modulation to cortical
plasticity in vivo. J. Neurosci. 31,
18155–18165.
Takemiya, T., Matsumura, K., Sugiura,
H., Yasuda, S., Uematsu, S., Akira, S.,
and Yamagata, K. (2011). Endothe-
lial microsomal prostaglandin E
synthase-1 facilitates neurotoxicity
by elevating astrocytic Ca2+ levels.
Neurochem. Int. 58, 489–496.
Tanabe, S., Heesen, M., Yoshizawa,
I., Berman, M. A., Luo, Y., Bleul,
C. C., Springer, T. A., Okuda,
K., Gerard, N., and Dorf, M.
E. (1997). Functional expression
of the CXC-chemokine receptor-
4/fusin on mouse microglial cells
and astrocytes. J. Immunol. 159,
905–911.
Verrall, L., Burnet, P. W., Betts, J. F.,
and Harrison, P. J. (2010). The neu-
robiology of D-amino acid oxidase
and its involvement in schizophre-
nia. Mol. Psychiatry 15, 122–137.
Vitkovic, L., Bockaert, J., and Jacque, C.
(2000). “Inflammatory” cytokines:
neuromodulators in normal brain?
J. Neurochem. 74, 457–471.
Volterra, A., and Meldolesi, J. (2005).
Astrocytes, from brain glue to com-
munication elements: the revolu-
tion continues. Nat. Rev. Neurosci. 6,
626–640.
Walz,W. (2000). Controversy surround-
ing the existence of discrete func-
tional classes of astrocytes in adult
gray matter. Glia 31, 95–103.
Wang, X., Arcuino, G., Takano, T., Lin,
J., Peng, W. G., Wan, P., Li, P., Xu, Q.,
Liu, Q. S., Goldman, S. A., and Ned-
ergaard, M. (2004). P2X7 receptor
inhibition improves recovery after
spinal cord injury. Nat. Med. 10,
821–827.
Wang, X., Lou, N., Xu, Q., Tian, G.
F., Peng, W. G., Han, X., Kang,
J., Takano, T., and Nedergaard,
M. (2006). Astrocytic Ca2+ signal-
ing evoked by sensory stimulation
in vivo. Nat. Neurosci. 9, 816–823.
Winship, I. R., Plaa, N., and Murphy,
T. H. (2007). Rapid astrocyte cal-
cium signals correlate with neuronal
activity and onset of the hemody-
namic response in vivo. J. Neurosci.
27, 6268–6272.
Wolosker, H., Blackshaw, S., and Sny-
der, S. H. (1999). Serine race-
mase: a glial enzyme synthesizing
D-serine to regulate glutamate-N-
methyl-D-aspartate neurotransmis-
sion. Proc. Natl. Acad. Sci. U.S.A. 96,
13409–13414.
Yagodin, S. V., Holtzclaw, L., Sheppard,
C. A., and Russell, J. T. (1994).
Nonlinear propagation of agonist-
induced cytoplasmic calcium waves
in single astrocytes. J. Neurobiol. 25,
265–280.
Zamanian, J. L., Xu, L., Foo, L. C., Nouri,
N., Zhou, L., Giffard, R. G., and Bar-
res, B. A. (2012). Genomic analysis
of reactive astrogliosis. J. Neurosci.
32, 6391–6410.
Zhang, H., Cao, H. J., Kimelberg, H.
K., and Zhou, M. (2011). Volume
www.frontiersin.org July 2012 | Volume 3 | Article 139 | 15
Agulhon et al. Gliotransmission in normal vs. reactive astrocytes
regulated anion channel currents
of rat hippocampal neurons and
their contribution to oxygen-and-
glucose deprivation induced neu-
ronal death. PLoS ONE 6, e16803.
doi:10.1371/journal.pone.0016803
Zhang, Y., Zhang, H., Feustel, P. J., and
Kimelberg, H. K. (2008). DCPIB,
a specific inhibitor of volume reg-
ulated anion channels (VRACs),
reduces infarct size in MCAo and the
release of glutamate in the ischemic
cortical penumbra. Exp. Neurol. 210,
514–520.
Zheng, J., Ghorpade, A., Niemann, D.,
Cotter, R. L., Thylin, M. R., Epstein,
L., Swartz, J. M., Shepard, R. B.,
Liu, X., Nukuna,A., and Gendelman,
H. E. (1999). Lymphotropic virions
affect chemokine receptor-mediated
neural signaling and apoptosis:
implications for human immun-
odeficiency virus type 1-associated
dementia. J. Virol. 73, 8256–8267.
Zhou, M., Schools, G. P., and Kimel-
berg, H. K. (2006). Development of
GLAST(+) astrocytes and NG2(+)
glia in rat hippocampus CA1:
mature astrocytes are electrophysio-
logically passive. J. Neurophysiol. 95,
134–143.
Zonta, M., Angulo, M. C., Gobbo, S.,
Rosengarten, B., Hossmann, K.
A., Pozzan, T., and Carmignoto,
G. (2003). Neuron-to-astrocyte
signaling is central to the dynamic
control of brain microcirculation.
Nat. Neurosci. 6, 43–50.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 15 May 2012; accepted: 26 June
2012; published online: 13 July 2012.
Citation: Agulhon C, Sun M-Y, Mur-
phy T, Myers T, Lauderdale K and
Fiacco TA (2012) Calcium signaling and
gliotransmission in normal vs. reactive
astrocytes. Front. Pharmacol. 3:139. doi:
10.3389/fphar.2012.00139
This article was submitted to Frontiers
in Neuropharmacology, a specialty of
Frontiers in Pharmacology.
Copyright © 2012 Agulhon, Sun, Mur-
phy, Myers, Lauderdale and Fiacco. This
is an open-access article distributed under
the terms of the Creative Commons Attri-
bution License, which permits use, distri-
bution and reproduction in other forums,
provided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Pharmacology | Neuropharmacology July 2012 | Volume 3 | Article 139 | 16
